VIA
THC icon

Vident Investment Advisory’s Tenet Healthcare THC Stock Holding History

Vident Investment Advisory’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-33,208
Closed -$1.74M – 1318
2022
Q2 		$1.74M Buy
33,208
+2,232
+7% +$155K 0.05% 440
2022
Q1 		$2.66M Buy
30,976
+872
+3% +$71.6K 0.07% 327
2021
Q4 		$2.46M Sell
30,104
-4,506
-13% -$329K 0.06% 359
2021
Q3 		$2.3M Sell
34,610
-3,488
-9% -$247K 0.07% 335
2021
Q2 		$2.55M Sell
38,098
-167
-0.4% -$10.4K 0.08% 308
2021
Q1 		$1.99M Buy
+38,265
New +$1.93M 0.07% 377
2019
Q1 		– Sell
-72,993
Closed -$1.25M – 804
2018
Q4 		$1.25M Sell
72,993
-15,493
-18% -$375K 0.07% 373
2018
Q3 		$2.52M Buy
88,486
+82,305
+1,332% +$2.72M 0.1% 284
2018
Q2 		$207K Buy
+6,181
New +$192K 0.01% 884
2015
Q4 		– Sell
-112
Closed -$4K – 800
2015
Q3 		$4K Sell
112
-1,052
-90% -$54.4K ﹤0.01% 921
2015
Q2 		$67K Buy
+1,164
New +$59.5K 0.01% 746

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $882M AUM 62.77% 1-Year Est. Return

Vident Investment Advisory's THC Position: Q3 2022 in Review

Vident Investment Advisory sold out of Tenet Healthcare (THC) in Q3 2022, closing a stake of 33,208 shares — an estimated $1.74M sold.

Vident Investment Advisory first reported a position in THC in Q2 2015 and held it in 11 quarters. The position peaked at $2.66M in Q1 2022. 360 funds tracked by Wall St. Rank hold THC as of Q3 2022.

  • Vident Investment Advisory reported no remaining Tenet Healthcare position as of Q3 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 33,208 Tenet Healthcare shares in Q3 2022, an estimated $1.74M.
  • Vident Investment Advisory first reported a position in Tenet Healthcare in Q2 2015 and held it in 11 quarters.
  • Vident Investment Advisory's Tenet Healthcare position peaked at $2.66M in Q1 2022.
  • 360 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2022.

Based on Vident Investment Advisory's 13F filing for Q3 2022, filed 14 Nov 2022.